Xencor Inc

XNCR NASDAQ Santé & Biotech États-Unis US98401F1057
12.16 $
2.79 %

Xencor Inc se concentre sur le développement de thérapies d'anticorps pour le traitement des maladies auto-immunes et du cancer.

Performance & Momentum

6 Months 28.72 %
1 Year 27.73 %
3 Years 55.16 %
5 Years 67.39 %

Similar stocks to Xencor Inc

Anantys Community

Be the first to share your analysis on Xencor Inc.

Take control
of your investments

Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.

  • Real-time multi-portfolio tracking
  • AI analysis of your positions
  • Counter your cognitive biases